Order Saypha® Volume w/ Lidocaine for Clinics

Saypha® Volume w/ Lidocaine is a sterile hyaluronic acid dermal filler for professional facial volume restoration and contour refinement. Licensed clinics and healthcare professionals can order the 1 mL prefilled syringe for treatment-room use in regulated aesthetic settings. Each unit contains hyaluronic acid 23 mg/mL with 0.3% lidocaine, supporting volumizing work while reducing injection discomfort during administration.

Med Wholesale Supplies supports B2B procurement for licensed clinics, med spas, and healthcare practices that need consistent access to authentic aesthetic supplies. Saypha Volume with Lidocaine 1ml fits clinics that document lot numbers, manage single-patient injectable inventory, and schedule filler sessions around trained provider availability.

Clinic Ordering, Price, and Account Access

Verified clinic accounts can buy Saypha Volume Lidocaine after signing in to view current pricing and submit purchase requests. The Saypha Volume price can vary by account tier, quantity, and procurement arrangement, so logged-in facilities should use the current unit cost shown during checkout or request a quote for multi-unit planning.

The 1 mL syringe format helps practices estimate product use by session, provider, and treatment area. For teams purchasing across several injectors or locations, unit-based ordering also simplifies reconciliation between appointment schedules and injectable inventory logs. If your clinic is standardizing a broader dermal filler range, the Saypha brand range provides a practical starting point for related Croma filler presentations.

New accounts may need facility verification before purchasing professional-use injectables. We may review order details and documentation to support appropriate clinic supply workflows. Orders are coordinated through verified supply channels with temperature-controlled handling when required and tracked US delivery.

What This Filler Is and How It Works

Saypha Volume Lidocaine dermal filler is an injectable hyaluronic acid gel used by qualified practitioners for volumetric correction. Hyaluronic acid is a water-binding molecule used in many soft-tissue fillers because it can support tissue hydration and structure after placement. In practice, the gel is positioned by a trained injector according to anatomy, treatment plan, and clinic protocol.

The product combines hyaluronic acid at 23 mg/mL with 0.3% lidocaine. Lidocaine is a local anesthetic included to improve procedural comfort during injection. This built-in anesthetic can reduce reliance on separate numbing steps, although clinics may still follow their usual comfort protocols when appropriate.

Saypha products are part of Croma’s aesthetic filler portfolio. For a broader category view, clinics planning inventory around contouring and rejuvenation may also review types of dermal fillers for facial volume, which explains how different filler classes and textures are selected for aesthetic goals.

Professional Applications and Treatment-Room Fit

Clinics may select this filler for provider-planned volume restoration and contour support in areas such as the midface, chin, or jawline when appropriate for the individual case. It may also be used in treatment plans that address facial deflation or deeper contour transitions. Final placement, volume, depth, and technique remain clinical decisions for trained injectors.

The Saypha Volume Lidocaine prefilled syringe supports controlled use in standard injectable workflows. Providers can work incrementally, place small aliquots, and shape contours according to tissue response. The inclusion of two 27G 1/2 needles gives the treatment room a ready needle pairing, while clinics that use cannulas or alternative techniques should follow their internal policies and the product instructions for use.

Why it matters: A single-patient 1 mL syringe helps align treatment plans with documentation, stock rotation, and chair-time planning.

For clinics building facial balancing protocols, facial volume restoration treatment considerations can help teams discuss where filler, neuromodulators, and other aesthetic modalities may fit within a professional consultation.

Key Features for Clinic Inventory

• Sterile injectable hyaluronic acid gel for professional use.
• Saypha Volume Lidocaine 1x1ml presentation for single-patient treatment planning.
• Hyaluronic acid concentration of 23 mg/mL.
• 0.3% lidocaine integrated for injection comfort.
• Prefilled syringe designed for treatment-room preparation.
• Two 27G 1/2 needles included in the box.
• Lot number and expiry support clinic documentation.
• Single-use format supports traceability and waste control.
• Useful for volumizing and contour-focused aesthetic protocols.
• Compatible with established sterile injectable handling procedures.

Composition, Pack Contents, and Documentation

Each unit contains one Saypha Volume Lidocaine syringe filled with 1 mL of sterile injectable gel. The formulation contains hyaluronic acid 23 mg/mL and lidocaine 0.3%. The box also includes two 27G 1/2 needles and instructions for use, supporting efficient setup in a clinical environment.

Lot number and expiry information should be captured at intake and again at the time of administration according to clinic policy. This documentation supports traceability, adverse event investigation, inventory rotation, and internal quality controls. Clinics that use barcode systems can align unit receipt, room assignment, and patient charting with standard operating procedures.

Benefits in Practice

The main operational benefit is predictable integration into established aesthetic workflows. A clinic can receive the unit, document it, store it according to the instructions for use, and allocate it to a trained injector for a scheduled filler appointment. The prefilled syringe reduces preparation steps compared with systems that require more assembly.

Integrated lidocaine is useful for longer contouring appointments or multi-area plans because it supports comfort at the point of injection. The filler’s volumizing profile can help providers restore shape while using conservative, staged augmentation when that approach fits the plan. For staff education around anesthetic-containing fillers, the role of lidocaine in dermal filler procedures explains why many clinics choose lidocaine-containing presentations.

Inventory teams also benefit from the simple 1 mL count. Practices can forecast usage by common treatment areas, track provider preferences, and plan reorders before peak aesthetic scheduling periods. A consistent SKU also helps multi-location groups compare usage patterns without relying on informal room-level stock estimates.

Storage, Handling, and Sterile Technique

Saypha Volume injectable gel should be handled as a sterile, single-use injectable product. Clinics should follow the included instructions for use, maintain clean preparation procedures, and avoid using any unit with compromised packaging, unclear labeling, or expired dating. Once a syringe is assigned for treatment, it should be used according to clinic sterile technique protocols.

Storage requirements should be taken from the manufacturer labeling and any distributor documentation included with the shipment. Receiving staff should inspect packaging on arrival, record lot and expiry, and place the unit into the correct storage location before clinical use. If your clinic manages multiple filler lines, separating lidocaine and non-lidocaine versions can reduce room setup errors.

Sharps disposal, syringe disposal, and unused product handling should follow local clinical waste procedures. Staff should also verify that the treatment room has appropriate needles, antiseptic supplies, emergency materials, and documentation tools before the patient enters the room.

Safety, Warnings, and Patient Screening

Dermal fillers should be administered only by trained healthcare professionals familiar with facial anatomy, injection depth, vascular risk, and complication management. Clinics should screen for relevant medical history, allergies, active skin infection, pregnancy or lactation considerations, prior filler placement, and procedures that may affect timing. Product suitability is determined by the treating professional, not by inventory availability alone.

Expected local reactions may include tenderness, swelling, bruising, redness, firmness, itching, or temporary discomfort at the injection site. More serious complications can include infection, nodules, vascular occlusion, tissue compromise, visual symptoms, or hypersensitivity reactions. Patients should receive appropriate aftercare instructions and clear guidance on when to contact the clinic urgently.

Because this formulation contains lidocaine, clinics should consider lidocaine sensitivity or contraindications during screening. Providers should avoid injecting into areas with active inflammation or infection and should not use compromised product. Emergency protocols, hyaluronidase access where appropriate, and staff training are important parts of responsible filler practice.

Authoritative background on hyaluronic acid properties is available through the NIH Bookshelf hyaluronic acid monograph. Manufacturer-level portfolio information is available from Croma-Pharma.

Related Saypha and Dermal Filler Choices

Clinics comparing Saypha fillers should evaluate gel behavior, intended treatment areas, lidocaine preference, syringe count, and provider technique. For practices that want a related volumizing option, Saypha® Volume Plus w/ Lidocaine may be considered within the same family. If a clinic wants the same volume-oriented category without integrated anesthetic, Saypha® Volume is a related non-lidocaine presentation.

For lower-volume correction or softer placement preferences, the broader Saypha range may also be relevant. Saypha® Filler w/ Lidocaine and Saypha® Rich can help clinics build a structured product set around different aesthetic indications and provider preferences.

Practices reviewing category-level purchasing can use wholesale dermal filler considerations for aesthetic practices to support procurement planning, staff training discussions, and portfolio standardization.

Procurement Planning for Licensed Practices

Saypha Volume cost should be considered alongside expected case mix, average syringe usage, provider scheduling, and expiration dating. A high-volume clinic may need routine replenishment, while a smaller aesthetic practice may prefer tighter unit counts to reduce holding time. The 1 mL format makes it easier to align purchasing with scheduled treatment blocks.

When ordering for multiple rooms or locations, assign receiving responsibility and keep one source of truth for lot numbers. Many clinics benefit from documenting receipt date, storage location, assigned provider, patient chart reference, and disposal. This level of tracking supports clinical accountability and helps purchasing teams identify reorder points before stock disruption affects appointments.

Quick tip: Record expiry dates during intake so older units are used first under your clinic’s rotation policy.

For larger groups, standing purchasing patterns can be coordinated around predictable procedure calendars. If your facility has lot-dating preferences, communicate them during the purchase process so the receiving team can plan intake and stock rotation appropriately.

Authoritative Sources

• Croma-Pharma manufacturer portfolio: official company and product-family information.
• NIH Bookshelf hyaluronic acid background: scientific background on hyaluronic acid properties.

This content is for informational purposes only and is not a substitute for professional medical advice.